David Robinson has stepped down as chairman, CEO and president of Ligand Pharmaceuticals to "pursue other interests." Current director Henry F. Blissenbach has been named chairman and interim CEO of the company.
Michael K. Lester, Radiant Research's chairman and chief executive officer, has announced his decision to retire as CEO. Pamela M. Spaniac, Radiant's current president and chief operating officer, will become chief executive officer and a director of the Company. Lester will remain executive chairman of the board of directors.
BioLife Solutions has named Michael Rice as its president and chief executive officer and a member of the board of directors.
Cerexa has named George H. Talbot, M.D., to the position of chief medical officer and executive vice president.
US Oncology announced that Richard P. McCook became the company's executive vice president and chief financial officer.
InterMune hired John Hodgman as its new chief financial officer. Norman Halleen stepped down from the post recently.
ProEthic Pharmaceuticals has appointed Joseph A. Medlin as the company's senior vice president finance and chief operating officer.
Neurobiological Technologies has named Craig W. Carlson as its vice president and chief financial officer.
Avalon Pharmaceuticals has appointed J. Michael Hamilton, M.D., to the newly created position of chief medical officer.
ArQule has named Nigel J. Rulewski, M.D. as chief medical officer.
CuraGen Corporation has named Paul M. Finigan to the newly created position of senior vice president and general counsel.
Alba Therapeutics has hired Stuart D. Sedlack as senior vice president, corporate development.
OraSure Technologies announced that Mark Kirtland has been appointed as the company's senior vice president, business development.
Northfield Laboratories has appointed John J. Hinds as vice president finance
Palatin Technologies has named Steven Fischkoff, M.D. to the position of vice president of clinical development.
Aastrom Biosciences has appointed Elmar R. Burchardt, M.D., Ph.D., to the new position of senior director medical affairs.
Optimer Pharmaceuticals has named Kevin P. Poulos as vice president of marketing and sales, a new position in the company.
Pheromone Sciences Corp. announced that Jannette Dufour, Ph.D. has joined its Scientific Advisory Board to assist the company with its diabetes product development.
Semafore Pharmaceuticals announced that Homer L. Pearce, M.D. has joined the company's Scientific Advisory Board.
Sangamo BioSciences has added Michael Gilman, Ph.D., to the company's Scientific Advisory Board.
Stem Cell Therapy International has appointed Sean C. Orr, M.D. to its Medical and Scientific Advisory Board.
VioQuest Pharmaceuticals has appointed Francis Giles, M.D. of the University of Texas MD Anderson Cancer Center to its Scientific Advisory Board as chairman.
Halozyme Therapeutics announced that Connie Matsui has been named to its board of directors.
Symyx Tech. has appointed Anthony Muller to the company's board of directors.
Shire plc has named Kate Nealon as a non executive director and a member of the remuneration committee.
MultiCell Technologies announced that Anthony Cataldo, co-chairman, has resigned as a member of the company's board of directors in order to pursue other interests.
Keryx Biopharmaceuticals announced the passing of Jonathan Spicehandler, M.D., a valued member of its board of directors. Spicehandler is the former chairman of Schering-Plough Research Institute and retired from the company in late June.